• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.酒精使用障碍患者中肝硬化和慢性胰腺炎诊断的阳性预测值:一项单中心研究
Dig Dis Sci. 2024 Feb;69(2):596-602. doi: 10.1007/s10620-023-08183-x. Epub 2023 Nov 29.
2
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
5
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.超声检查在酒精性肝病患者中对酒精性肝硬化的诊断作用
Cochrane Database Syst Rev. 2016 Mar 2;3(3):CD011602. doi: 10.1002/14651858.CD011602.pub2.
6
Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C.基于四项因素(FIB-4)评分或 Forns 指数的成人慢性丙型肝炎肝纤维化分期。
Cochrane Database Syst Rev. 2024 Aug 13;8(8):CD011929. doi: 10.1002/14651858.CD011929.pub2.
7
Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.血清淀粉酶、脂肪酶以及尿胰蛋白酶原和淀粉酶用于急性胰腺炎的诊断。
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD012010. doi: 10.1002/14651858.CD012010.pub2.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Alcohol Use Disorder Polygenic Score Compared With Family History and ADH1B.酒精使用障碍多基因评分与家族史及乙醇脱氢酶1B的比较。
JAMA Netw Open. 2024 Dec 2;7(12):e2452705. doi: 10.1001/jamanetworkopen.2024.52705.
10
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.

本文引用的文献

1
Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.国际疾病分类第 10 版编码对肝硬化及门静脉高压并发症的准确性。
Dig Dis Sci. 2022 Aug;67(8):3623-3631. doi: 10.1007/s10620-021-07282-x. Epub 2021 Oct 21.
2
International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.国际疾病分类代码可用于在管理数据库中识别肝硬化。
Dig Dis Sci. 2022 Jun;67(6):2107-2122. doi: 10.1007/s10620-021-07076-1. Epub 2021 Jun 6.
3
International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club.国际诊断性内镜超声在慢性胰腺炎管理中作用的共识指南。该指南由协作制定慢性胰腺炎国际共识指南的工作组、国际胰腺病学会、美国胰腺协会、日本胰腺学会和欧洲胰腺俱乐部推荐。
Pancreatology. 2020 Jul;20(5):822-827. doi: 10.1016/j.pan.2020.05.025. Epub 2020 Jun 18.
4
Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.饮酒与肝硬化风险:系统评价和荟萃分析。
Am J Gastroenterol. 2019 Oct;114(10):1574-1586. doi: 10.14309/ajg.0000000000000340.
5
The Use of International Classification of Diseases Codes to Identify Patients with Pancreatitis: A Systematic Review and Meta-analysis of Diagnostic Accuracy Studies.利用国际疾病分类代码识别胰腺炎患者:诊断准确性研究的系统评价和荟萃分析。
Clin Transl Gastroenterol. 2018 Oct 4;9(10):191. doi: 10.1038/s41424-018-0060-1.
6
The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis.Rosemont 诊断标准与日本“不确定”“提示”“可能”和“早期”慢性胰腺炎诊断标准的诊断价值。
Pancreatology. 2018 Oct;18(7):774-784. doi: 10.1016/j.pan.2018.08.002. Epub 2018 Aug 7.
7
Alcoholic liver disease.酒精性肝病。
Nat Rev Dis Primers. 2018 Aug 16;4(1):16. doi: 10.1038/s41572-018-0014-7.
8
International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club.关于早期慢性胰腺炎的国际共识声明。慢性胰腺炎国际共识指南工作组与国际胰腺病协会、美国胰腺协会、日本胰腺学会、胰腺节工作组和欧洲胰腺俱乐部合作提出的建议。
Pancreatology. 2018 Jul;18(5):516-527. doi: 10.1016/j.pan.2018.05.008. Epub 2018 May 21.
9
Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis.粪便弹性蛋白酶-1 检测在外分泌胰腺功能不全诊断中的性能:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1220-1228.e4. doi: 10.1016/j.cgh.2018.01.027. Epub 2018 Jan 31.
10
Alcohol Consumption as a Risk Factor for Acute and Chronic Pancreatitis: A Systematic Review and a Series of Meta-analyses.饮酒作为急性和慢性胰腺炎的风险因素:系统评价和一系列荟萃分析。
EBioMedicine. 2015 Nov 14;2(12):1996-2002. doi: 10.1016/j.ebiom.2015.11.023. eCollection 2015 Dec.

酒精使用障碍患者中肝硬化和慢性胰腺炎诊断的阳性预测值:一项单中心研究

Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.

作者信息

Sun Yujie, Lu Michael, Feldman Robert, Saul Melissa, Althouse Andrew, Arteel Gavin, Yadav Dhiraj

机构信息

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Center for Research on Health Care Data Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

出版信息

Dig Dis Sci. 2024 Feb;69(2):596-602. doi: 10.1007/s10620-023-08183-x. Epub 2023 Nov 29.

DOI:10.1007/s10620-023-08183-x
PMID:38019381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12057044/
Abstract

BACKGROUND

Although accuracy of diagnosis codes for cirrhosis and chronic pancreatitis (CP) has been evaluated in multiple studies, none have focused on patients with alcohol use disorders (AUD). We evaluated the positive predictive value (PPV) for a verified diagnosis of cirrhosis and CP in AUD patients treated at a tertiary care center.

METHODS

We performed a detailed review of electronic health records for AUD patients assigned ICD-9 or 10 codes for alcoholic cirrhosis (ALC) (n = 199), CP (n = 200), or both (n = 200). We calculated PPV for a verified diagnosis of cirrhosis and CP and performed multivariable regression analysis to assess the impact of relevant factors on PPV for a verified diagnosis.

RESULTS

PPV of cirrhosis was 81.2% (95% CI 77.0 to 84.9%) which increased to 87.5% (95% CI 83.8 to 90.6%) if the definition was relaxed to include alcohol-related hepatitis. PPV of CP was 54.5% (95% CI 49.5 to 59.5%) which increased to 78% (95% CI 73.6 to 82.0%) when recurrent acute pancreatitis was included in the definition. In multivariable analyses, the odds of a verified diagnosis were significantly higher in individuals aged 65+ years for both cirrhosis (OR 12.23, 95% CI 2.19 to 68.42) and CP (OR 8.84, 95% CI 2.7 to 28.93) and in ever smokers for CP (OR 1.95, 95% CI 1.05 to 3.65).

CONCLUSION

PPV for diagnosis codes in AUD patients is high for a verified diagnosis of cirrhosis but only modest for CP. While administrative datasets can provide reliable information for cirrhosis, future studies should focus on ways to boost the diagnostic validity of administrative datasets for CP.

摘要

背景

尽管多项研究已对肝硬化和慢性胰腺炎(CP)诊断编码的准确性进行了评估,但尚无研究聚焦于酒精使用障碍(AUD)患者。我们评估了在一家三级医疗中心接受治疗的AUD患者中,经证实的肝硬化和CP诊断的阳性预测值(PPV)。

方法

我们对分配了国际疾病分类第九版(ICD - 9)或第十版(ICD - 10)酒精性肝硬化(ALC)编码(n = 199)、CP编码(n = 200)或两者皆有编码(n = 200)的AUD患者的电子健康记录进行了详细审查。我们计算了经证实的肝硬化和CP诊断的PPV,并进行多变量回归分析,以评估相关因素对经证实诊断的PPV的影响。

结果

肝硬化的PPV为81.2%(95%置信区间77.0%至84.9%),如果放宽定义以纳入酒精性肝炎,该值将增至87.5%(95%置信区间83.8%至90.6%)。CP的PPV为54.5%(95%置信区间49.5%至59.5%),当定义中纳入复发性急性胰腺炎时,该值增至78%(95%置信区间73.6%至82.0%)。在多变量分析中,65岁及以上个体经证实诊断为肝硬化(比值比12.23,95%置信区间2.19至68.42)和CP(比值比8.84,95%置信区间2.7至28.93)的几率显著更高,而曾经吸烟者经证实诊断为CP的几率也更高(比值比1.95,95%置信区间1.05至3.65)。

结论

AUD患者诊断编码对于经证实的肝硬化诊断的PPV较高,但对于CP诊断仅为中等水平。虽然行政数据集可为肝硬化提供可靠信息,但未来研究应聚焦于提高行政数据集对CP诊断有效性的方法。